Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Protagenic Therapeutics ( (PTIX) ) is now available.
Protagenic Therapeutics, Inc. recently closed a private placement deal raising $1.275 million, offering nearly two million shares of common stock and warrants. The funds will bolster the company’s working capital, furthering its mission to innovate in neuro-active peptide therapeutics. As a leader in biopharmaceuticals, Protagenic aims to address stress-related disorders with its cutting-edge treatments.
See more data about PTIX stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money